Cetuximab as salvage therapy in 82 year old women with metastatic colon cancer

被引：0
|
作者：
Krzemieniecki, Krzysztof [1 ]
机构：
[1] Uniwersytetu Med Krakowie, Coll Med, Klin Onkol, Ul Sniadeckich 10, PL-31531 Krakow, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2012年 / 8卷 / 02期
关键词：
metastatic colon cancer; elderly patients; cetuximab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Anticancer treatment offered to elderly requests basic knowledge on geriatric problems and understanding the limits related to reduced functional reserves. Cetuximab was prescribed as the rescue monotherapy to 82 years old women with metastatic colon cancer following failure of systemic treatment. The decrease in bothersome disease symptoms and temporary remission of metastatic lesions revealed in the imaging assessment were observed during treatment. Patient survived additional 10 months. Treatment was well tolerated and toxicity was easy manageable. Monotherapy with cetuximab can be a valuable palliative option in the adequately selected patients.
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [21] Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
    A. Matrone
    A. Prete
    A. Nervo
    A. Ragni
    L. Agate
    E. Molinaro
    C. Giani
    L. Valerio
    E. Minaldi
    A. Piovesan
    R. Elisei
    Journal of Endocrinological Investigation, 2021, 44 : 2139 - 2151
  • [22] Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer
    Matrone, A.
    Prete, A.
    Nervo, A.
    Ragni, A.
    Agate, L.
    Molinaro, E.
    Giani, C.
    Valerio, L.
    Minaldi, E.
    Piovesan, A.
    Elisei, R.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (10) : 2139 - 2151
  • [23] Systemic Therapy for Metastatic Colon Cancer: New Frontiers
    Pumpalova, Yoanna S.
    CLINICS IN COLON AND RECTAL SURGERY, 2024,
  • [24] Metastatic Pancreatic Cancer in 19-Year-Old
    Yarra, Pradeep
    Thakur, Kshitij
    Tripathi, Nishant
    Aknabi, Olalekan
    Kudaravalli, Praneeth
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1629 - S1629
  • [25] Metastatic Colon Cancer Likely Secondary to Mixed Germ Cell Ovarian Cancer in a 21-year-old Asian Female
    Chintanaboina, Jayakrishna
    Akhtar, Nabeel
    Bethards, Deborah
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S790 - S791
  • [26] Cetuximab as salvage monotherapy in chemotherapy-refractory metastatic colorectal cancer: A single-center report
    Mekata, Eiji
    Endo, Yoshihiro
    Sonoda, Hiromichi
    Shimizu, Tomoharu
    Kawai, Yuki
    Umeda, Tomoko
    Shiomi, Hisanori
    Naka, Shigeyuki
    Kubota, Yoshihiro
    Murata, Satoshi
    Yamamoto, Hiroshi
    Abe, Hajime
    Tani, Tohru
    ONCOLOGY LETTERS, 2013, 6 (04) : 1011 - 1014
  • [27] Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report
    Fukui, Taro
    Suzuki, Koichi
    Tamaki, Sawako
    Abe, Iku
    Endo, Yuhei
    Ishikawa, Hideki
    Kakizawa, Nao
    Watanabe, Fumiaki
    Saito, Masaaki
    Tsujinaka, Shingo
    Futsuhara, Kazushige
    Miyakura, Yasuyuki
    Noda, Hiroshi
    Rikiyama, Toshiki
    SURGICAL CASE REPORTS, 2019, 5 (01)
  • [28] Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report
    Taro Fukui
    Koichi Suzuki
    Sawako Tamaki
    Iku Abe
    Yuhei Endo
    Hideki Ishikawa
    Nao Kakizawa
    Fumiaki Watanabe
    Masaaki Saito
    Shingo Tsujinaka
    Kazushige Futsuhara
    Yasuyuki Miyakura
    Hiroshi Noda
    Toshiki Rikiyama
    Surgical Case Reports, 5
  • [29] Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
    Laurent-Puig, Pierre
    Cayre, Anne
    Manceau, Gilles
    Buc, Emmanuel
    Bachet, Jean-Baptiste
    Lecomte, Thierry
    Rougier, Philippe
    Lievre, Astrid
    Landi, Bruno
    Boige, Valerie
    Ducreux, Michel
    Ychou, Marc
    Bibeau, Frederic
    Bouche, Olivier
    Reid, Julia
    Stone, Steven
    Penault-Llorca, Frederique
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 5924 - 5930
  • [30] Successful and well-tolerated second line therapy with Cetuximab, irinotecan, and raltitrexed in progressive liver disease due to metastatic colon cancer
    Geurs F.
    Vandewaeter S.
    Ponette S.
    Ponette J.
    Knape S.
    Demetter P.
    Journal of Gastrointestinal Cancer, 2008, 39 (1-4) : 26 - 28
12345